- Home
- INBX
INBX
Inhibrx Inc.
as 11-21-2024 4:00pm EST
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | LA JOLLA |
| Market Cap: | 222.5M | IPO Year: | 2020 |
| Target Price: | N/A | AVG Volume (30 days): | 70.4K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 119.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $10.80 - $18.95 | Next Earning Date: | 11-14-2024 |
| Revenue: | $1,568,000 | Revenue Growth: | 19.24% |
| Revenue Growth (this year): | -93.76% | Revenue Growth (next year): | N/A |
Latest Inhibrx Inc. News
INBX Breaking Stock News: Dive into INBX Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 days ago
The recent drop in prices must have disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) institutional investors who own 43% of the shares
PR Newswire
7 days ago
Inhibrx Biosciences Reports Third Quarter 2024 Financial Results
PR Newswire
17 days ago
Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation
Argus Research
a month ago
Daily – Vickers Top Buyers & Sellers for 10/08/2024
MT Newswires
2 months ago
Inhibrx Biosciences Insider Bought Shares Worth $629,117, According to a Recent SEC Filing
GuruFocus.com
2 months ago
Director Kristiina Vuori Purchases Shares of Inhibrx Biosciences Inc (INBX)
MT Newswires
3 months ago
Inhibrx Biosciences Insider Bought Shares Worth $1,037,328, According to a Recent SEC Filing
PR Newswire
3 months ago
Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
Compare INBX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "INBX Inhibrx Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.